Cost analysis of CHOP (-like) chemotherapy regimens for patients with newly diagnosed aggressive non-Hodgkin's lymphoma.

scientific article

Cost analysis of CHOP (-like) chemotherapy regimens for patients with newly diagnosed aggressive non-Hodgkin's lymphoma. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1034/J.1600-0609.2002.02772.X
P698PubMed publication ID12431240

P50authorHanneke C Kluin-NelemansQ50757186
P2093author name stringB Löwenberg
R Willemze
P Sonneveld
P C Huijgens
L F Verdonck
L M Faber
C A Uyl-de Groot
M van Agthoven
P2860cites workA predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors ProjectQ28251216
Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphomaQ28297805
Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphomaQ28316407
Survival in patients with intermediate or high grade non-Hodgkin's lymphoma: meta-analysis of randomized studies comparing third generation regimens with CHOPQ28346778
Treatment of non-Hodgkin's lymphomaQ40885119
Survival of patients with cancerQ42114148
Standard chemotherapy with or without high-dose chemotherapy for aggressive non-Hodgkin's lymphoma: randomized phase III EORTC studyQ43514960
Evaluating the financial impact of clinical trials in oncology: results from a pilot study from the Association of American Cancer Institutes/Northwestern University clinical trials costs and charges projectQ50134451
Age-specific differences in the diagnostics and treatment of cancer patients aged 50 years and older in the province of Limburg, The Netherlands.Q50994497
Cost analysis and quality of life assessment comparing patients undergoing autologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed non-Hodgkin's lymphoma or Hodgkin's disease. a prosQ53474552
CHOP versus MACOP-B in aggressive lymphoma--a Nordic Lymphoma Group randomised trial.Q53537168
Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin's lymphoma. The Australian and New Zealand Lymphoma GroupQ71617622
National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification ProjectQ71859454
CHOP vs. ProMACE-CytaBOM in the treatment of aggressive non-Hodgkin's lymphomas: long-term results of a multicenter randomized trial.(PETHEMA: Spanish Cooperative Group for the Study of Hematological Malignancies Treatment, Spanish Society of HematoQ72997742
Impact of clinical trials on the cost of cancer careQ73821541
CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative StudyQ74082921
Extrapolation of cost-effectiveness information to local settingsQ77165307
Critical reviews of economic analyses in order to make health care decisions for cancerQ77713867
Elderly patients with non-Hodgkin's lymphoma: population-based results in The NetherlandsQ77713990
P433issue4
P921main subjectchemotherapyQ974135
P304page(s)213-220
P577publication date2002-10-01
P1433published inEuropean Journal of HaematologyQ15765799
P1476titleCost analysis of CHOP (-like) chemotherapy regimens for patients with newly diagnosed aggressive non-Hodgkin's lymphoma
P478volume69

Reverse relations

cites work (P2860)
Q45252389Cost-effectiveness of rituximab (MabThera) in diffuse large B-cell lymphoma in The Netherlands
Q37609370Costs of multiple myeloma and associated skeletal-related events in The Netherlands
Q73035188Costs of prostate cancer, metastatic to the bone, in the Netherlands
Q35967345Economic assessment in the management of non-Hodgkin's lymphoma
Q73560905Recent publications in hematological oncology

Search more.